Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Truway Portable Diagnostic Devices for Early Detection of Chronic Conditions
NCT07209527Phase 1Enrolling by invitation
- Start
- Oct 2025
- Primary completion
- Oct 2028
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial (2 arms). Primary endpoints: Rate of Early Detection of Chronic Conditions at 6 months and Improvement in Glycemic Control at 6 months. Started Oct 2025; status: enrolling by invitation.
Beyond the preview
Go deeper on NCT07209527.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07209527.